Estimation of smooth ROC curves for biomarkers with limits of detection
- PMID: 28786136
- PMCID: PMC5679135
- DOI: 10.1002/sim.7394
Estimation of smooth ROC curves for biomarkers with limits of detection
Abstract
Protein biomarkers found in plasma are commonly used for cancer screening and early detection. Measurements obtained by such markers are often based on different assays that may not support detection of accurate measurements due to a limit of detection. The ROC curve is the most popular statistical tool for the evaluation of a continuous biomarker. However, in situations where limits of detection exist, the empirical ROC curve fails to provide a valid estimate for the whole spectrum of the false positive rate (FPR). Hence, crucial information regarding the performance of the marker in high sensitivity and/or high specificity values is not revealed. In this paper, we address this problem and propose methods for constructing ROC curve estimates for all possible FPR values. We explore flexible parametric methods, transformations to normality, and robust kernel-based and spline-based approaches. We evaluate our methods though simulations and illustrate them in colorectal and pancreatic cancer data.
Keywords: Box-Cox; ROC; biomarker; cancer; censoring; classification; early detection; generalized gamma; kernels; limit of detection; spline.
Copyright © 2017 John Wiley & Sons, Ltd.
Figures


Similar articles
-
Smooth ROC curves and surfaces for markers subject to a limit of detection using monotone natural cubic splines.Biom J. 2013 Sep;55(5):719-40. doi: 10.1002/bimj.201200158. Epub 2013 Apr 3. Biom J. 2013. PMID: 23553499
-
Comparison of two correlated ROC curves at a given specificity or sensitivity level.Stat Med. 2016 Oct 30;35(24):4352-4367. doi: 10.1002/sim.7008. Epub 2016 Jun 20. Stat Med. 2016. PMID: 27324068 Free PMC article.
-
Semiparametric transformation models for multiple continuous biomarkers in ROC analysis.Biom J. 2015 Sep;57(5):808-33. doi: 10.1002/bimj.201400043. Epub 2015 Jul 3. Biom J. 2015. PMID: 26138227
-
Receiver operating characteristic (ROC) curve: practical review for radiologists.Korean J Radiol. 2004 Jan-Mar;5(1):11-8. doi: 10.3348/kjr.2004.5.1.11. Korean J Radiol. 2004. PMID: 15064554 Free PMC article. Review.
-
Statistical Considerations in the Evaluation of Continuous Biomarkers.J Nucl Med. 2021 May 10;62(5):605-611. doi: 10.2967/jnumed.120.251520. Epub 2021 Feb 12. J Nucl Med. 2021. PMID: 33579807 Free PMC article. Review.
Cited by
-
Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies.Res Methods Med Health Sci. 2023 Jan;4(1):34-48. doi: 10.1177/26320843221141056. Epub 2022 Dec 13. Res Methods Med Health Sci. 2023. PMID: 37009524 Free PMC article.
-
Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.EBioMedicine. 2020 Jun;56:102811. doi: 10.1016/j.ebiom.2020.102811. Epub 2020 Jun 5. EBioMedicine. 2020. PMID: 32512514 Free PMC article.
-
Estimating transformations for evaluating diagnostic tests with covariate adjustment.Stat Methods Med Res. 2023 Jul;32(7):1403-1419. doi: 10.1177/09622802231176030. Epub 2023 Jun 6. Stat Methods Med Res. 2023. PMID: 37278185 Free PMC article.
-
A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits-Application to diagnosing early stage Alzheimer disease.Stat Methods Med Res. 2022 May;31(5):882-898. doi: 10.1177/09622802211072511. Epub 2022 Jan 19. Stat Methods Med Res. 2022. PMID: 35044258 Free PMC article.
References
-
- Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of Biomarker Development for Early Detection of Cancer. Journal of National Cancer Institute. 2001;93:1054–1061. - PubMed
-
- Taguchi A, Rho Jh, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, Kucherlapati R, Boutin AT, Wang AY, DePinho RA, Feng Z, Lampe PD, Hanash SM. MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas. Cancer Prevention Research. 2015 doi: 10.1158/1940-6207.CAPR-15-0077. - DOI - PMC - PubMed
-
- McLaughlin R, O'Hanlon D, Kerin M, Kenny P, Grimes H, Given HF. Are elevated Levels of the Tumour Marker CA19-9 of any clinical significance?-An evaluation. Clin Chem Lab Med. 1999;168(2):124–126. - PubMed
-
- Kim HR, Lee CH, Han SK, Shim YS, Yim JJ. Increased CA 19-9 level in patients without malignant disease. Clin Chem Lab Med. 2009;47:750–754. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources